That's life ... it sucks and have no control over it !

... thanks everyone for keeping the board alive.

Back in town, should be back posting tomorrow.

Sorry, should have posted something before leaving. Took a few days off, one of my best friend for more than 40yrs passed away.

Nice trade buddy ...

Lee .... we need to talk ! lol

Done ! May be back later.

Done for now ... may be back later ! Have a nice evening everyone.

Update: WBAI 12.83 -1.67 (-11.52%)

Update: COO 183.45 +3.19 (1.77%) < link back

Valeant initiates debt offering

Valeant Pharmaceuticals (NYSE:VRX) commences a private offering of $9.6B aggregate principal amount of senior unsecured notes. The debt, together with the company's incremental term loan facilities and cash on hand, will fund the acquisition of Salix Pharmaceuticals (NASDAQ:SLXP).

Valeant initiates debt offering

Valeant Pharmaceuticals (NYSE:VRX) commences a private offering of $9.6B aggregate principal amount of senior unsecured notes. The debt, together with the company's incremental term loan facilities and cash on hand, will fund the acquisition of Salix Pharmaceuticals (NASDAQ:SLXP).

Global Brass and Copper beats by $0.05, beats on revenue

Global Brass and Copper (NYSE:BRSS): Q4 EPS of $0.28 beats by $0.05.
Revenue of $390.3M (-5.5% Y/Y) beats by $34.96M.

Atlas Financial Holdings beats by $0.07, misses on revenue

Atlas Financial Holdings (NASDAQ:AFH): Q4 EPS of $0.35 beats by $0.07.
Revenue of $28.4M (+35.6% Y/Y) misses by $0.06M.

VNET 17.73 +0.40 (2.31%) < link back

Update: NTLS 6.04 +0.14 (2.37%) < link back

Update: AKBA 11.45 +0.30 (2.69%) < link back

Update: THRX 20.20 +0.60 (3.06%) < link back

Update: RVNC 17.97 +0.65 (3.75%) < link back

Update: RESN 12.99 +1.17 (9.90%) < link back

Update: WLL 37.71 +3.68 (10.81%)

Counting the days D !

S&P raises Alcoa's outlook to stable from negative

S&P raises its ratings outlook on Alcoa (NYSE:AA) to stable from negative, citing the company's efforts to strengthen credit measures and restructure its businesses, focusing on higher margin products in its engineered products and solutions segment, closing high cost plants, and investing on improving its upstream businesses.
The ratings agency says it expects Alcoa to "maintain its strong liquidity position, improve its balance sheet, and continue to reduce its cost structure."
Alcoa's deal to pay $1.5B to purchase titanium product producer RTI International Metals and the commodity curtailment review announced last week reinforce that the company is "dead serious" about transitioning its portfolio, Sterne Agee writes.
Shares +0.4% AH after falling 5.4% during regular trade, as investors felt the company may have overpaid for RTI.

S&P raises Alcoa's outlook to stable from negative

S&P raises its ratings outlook on Alcoa (NYSE:AA) to stable from negative, citing the company's efforts to strengthen credit measures and restructure its businesses, focusing on higher margin products in its engineered products and solutions segment, closing high cost plants, and investing on improving its upstream businesses.
The ratings agency says it expects Alcoa to "maintain its strong liquidity position, improve its balance sheet, and continue to reduce its cost structure."
Alcoa's deal to pay $1.5B to purchase titanium product producer RTI International Metals and the commodity curtailment review announced last week reinforce that the company is "dead serious" about transitioning its portfolio, Sterne Agee writes.
Shares +0.4% AH after falling 5.4% during regular trade, as investors felt the company may have overpaid for RTI.

Skyworks replacing PetSmart in S&P 500

Skyworks (NASDAQ:SWKS) will replace PetSmart in the S&P 500 following Wednesday's close. PetSmart is about to be taken private.
SWKS +2.1% AH to $94.09. Shares rose 1.5% in regular trading, making new highs along the way. Canaccord hiked its target by $12 to $102 earlier today, citing upbeat comments from management at last week's Mobile World Congress.
Canaccord: "We believe Skyworks strong portfolio of integrated solutions should increase Skyworks' [addressable market] for the fast growing RFIC market and enable Skyworks to capture RF $-content share in the LTE smartphone market. In fact, we believe Skyworks' broad portfolio should enable dollar content share growth in both Apple's and Samsung's premium tier smartphones during 2015 and grow content share in the fast growing Chinese LTE smartphone market."

Phoenix New Media beats by RMB0.02, misses on revenue

Phoenix New Media (NYSE:FENG): Q4 EPS of RMB0.84 beats by RMB0.02.
Revenue of RMB438.1M (+9.5% Y/Y) misses by RMB13.96M.

After Hours Movers

Top Gaining Stocks
Price %Change
UPL Ultra Petroleum Co... 16.35 11.38%
RESN Resonant Inc 14.40 10.85%
HTBX Heat Biologics Inc... 8.96 7.95%
SMCI Super Micro Comput... 40.87 7.38%
BIOS Bioscrip Inc. 4.55 5.91%
EDAP Edap Tms S.a. 3.79 5.87%
CPLP Capital Product Pa... 9.78 5.83%
CAFE ipath Pure Beta Co... 17.29 5.00%
CEVA Ceva Inc. 21.60 4.96%
PNR Pentair Plc 67.25 4.67%
WATT Energous Corp 11.29 4.45%
EGO Eldorado Gold Corp... 4.85 4.30%
IMN Imation Corp. 4.42 4.00%
BIOC Biocept Inc 3.50 3.86%
MRGE Merge Healthcare I... 4.31 3.81%
URBN Urban Outfitters I... 40.99 3.75%
WBAI 500 Com Ltd. Adr (... 13.27 3.44%
SXC Suncoke Energy Inc... 17.64 3.40%
CTRV Contravir Pharms I... 4.64 3.23%
HFBL Home Federal Banco... 20.00 3.09%

Top Losing Stocks
Price %Change
KFY Korn/ferry Interna... 27.50 -13.52%
MIND Mitcham Industries... 5.25 -13.51%
WPRT Westport Innovatio... 5.10 -10.21%
TITN Titan Machinery In... 12.86 -8.40%
UNFI United Natural Foo... 75.53 -7.31%
RM Regional Managemen... 15.00 -7.18%
AIQ Alliance Healthcar... 21.74 -7.13%
VNET 21vianet Group Inc... 16.51 -6.88%
ARAY Accuray Incorporat... 8.15 -6.43%
REPH Recro Pharma Inc 4.22 -6.22%
ROSE Rosetta Resources ... 17.07 -4.96%
NDLS Noodles & Company ... 17.20 -4.91%
AMKR Amkor Technology I... 8.89 -4.82%
CLMT Calumet Specialty ... 26.50 -4.81%
TTPH Tetraphase Pharmac... 34.28 -4.78%
MR Mindray Medical In... 28.02 -4.76%
CTCT Constant Contact I... 38.21 -3.85%
EEP Enbridge Energy Pa... 36.50 -3.77%
MAIN Main Street Capita... 30.00 -3.66%
CMTL Comtech Telecommun... 33.00 -3.62%

After Hours Movers

Top Gaining Stocks
Price %Change
UPL Ultra Petroleum Co... 16.35 11.38%
RESN Resonant Inc 14.40 10.85%
HTBX Heat Biologics Inc... 8.96 7.95%
SMCI Super Micro Comput... 40.87 7.38%
BIOS Bioscrip Inc. 4.55 5.91%
EDAP Edap Tms S.a. 3.79 5.87%
CPLP Capital Product Pa... 9.78 5.83%
CAFE ipath Pure Beta Co... 17.29 5.00%
CEVA Ceva Inc. 21.60 4.96%
PNR Pentair Plc 67.25 4.67%
WATT Energous Corp 11.29 4.45%
EGO Eldorado Gold Corp... 4.85 4.30%
IMN Imation Corp. 4.42 4.00%
BIOC Biocept Inc 3.50 3.86%
MRGE Merge Healthcare I... 4.31 3.81%
URBN Urban Outfitters I... 40.99 3.75%
WBAI 500 Com Ltd. Adr (... 13.27 3.44%
SXC Suncoke Energy Inc... 17.64 3.40%
CTRV Contravir Pharms I... 4.64 3.23%
HFBL Home Federal Banco... 20.00 3.09%

Top Losing Stocks
Price %Change
KFY Korn/ferry Interna... 27.50 -13.52%
MIND Mitcham Industries... 5.25 -13.51%
WPRT Westport Innovatio... 5.10 -10.21%
TITN Titan Machinery In... 12.86 -8.40%
UNFI United Natural Foo... 75.53 -7.31%
RM Regional Managemen... 15.00 -7.18%
AIQ Alliance Healthcar... 21.74 -7.13%
VNET 21vianet Group Inc... 16.51 -6.88%
ARAY Accuray Incorporat... 8.15 -6.43%
REPH Recro Pharma Inc 4.22 -6.22%
ROSE Rosetta Resources ... 17.07 -4.96%
NDLS Noodles & Company ... 17.20 -4.91%
AMKR Amkor Technology I... 8.89 -4.82%
CLMT Calumet Specialty ... 26.50 -4.81%
TTPH Tetraphase Pharmac... 34.28 -4.78%
MR Mindray Medical In... 28.02 -4.76%
CTCT Constant Contact I... 38.21 -3.85%
EEP Enbridge Energy Pa... 36.50 -3.77%
MAIN Main Street Capita... 30.00 -3.66%
CMTL Comtech Telecommun... 33.00 -3.62%

SteadyMed on deck for IPO

Rehovot, Israel-based SteadyMed is set for its IPO of 4.25M shares of common stock at $12 - 14. Underwriters over-allotment is an additional 637.5K shares. It will trade under the symbol "STDY."
The specialty pharmaceutical company focuses on the development and commercialization of therapeutics that address the limitations of market-leading products in certain orphan and other well-defined, high-margin specialty markets. Its lead product candidate is Trevyent, a small, pre-filled, single-use delivery device that delivers parenteral treprostinil (Remodulin) at a pre-programmed rate to patients with pulmonary arterial hypertension. Its value proposition is a more convenient dosing regimen enabled by its PatchPump technology which delivers a steady flow of drug to the patient either intravenously or subcutaneously.
The company intends to apply for Orphan Drug designation with the FDA by mid-year and submit an New Drug Application (NDA) by Q1 2016.
Net losses for 2014, 2013 and 2012 were ($19.0M), ($7.9M) and ($4.1M), respectively. Operations consumed $13.4M in cash in 2014 and $7.5M in 2013.
Related ticker: (NASDAQ:UTHR)

SteadyMed on deck for IPO

Rehovot, Israel-based SteadyMed is set for its IPO of 4.25M shares of common stock at $12 - 14. Underwriters over-allotment is an additional 637.5K shares. It will trade under the symbol "STDY."
The specialty pharmaceutical company focuses on the development and commercialization of therapeutics that address the limitations of market-leading products in certain orphan and other well-defined, high-margin specialty markets. Its lead product candidate is Trevyent, a small, pre-filled, single-use delivery device that delivers parenteral treprostinil (Remodulin) at a pre-programmed rate to patients with pulmonary arterial hypertension. Its value proposition is a more convenient dosing regimen enabled by its PatchPump technology which delivers a steady flow of drug to the patient either intravenously or subcutaneously.
The company intends to apply for Orphan Drug designation with the FDA by mid-year and submit an New Drug Application (NDA) by Q1 2016.
Net losses for 2014, 2013 and 2012 were ($19.0M), ($7.9M) and ($4.1M), respectively. Operations consumed $13.4M in cash in 2014 and $7.5M in 2013.
Related ticker: (NASDAQ:UTHR)

NACCO reports Q4 results

NACCO (NYSE:NC): Q4 EPS of $3.52
Revenue of $297.3M (-4.7% Y/Y).

U.S. Auto Parts Network misses by $0.01, beats on revenue

U.S. Auto Parts Network (NASDAQ:PRTS): Q4 EPS of -$0.07 misses by $0.01.
Revenue of $70.57M (+18.1% Y/Y) beats by $3.62M.

Resonant +10.9%; second customer announced

Resonant (NASDAQ:RESN) has landed "a second customer for the design of an RF filter" featuring the company's ISN technology, which aims to enable tunable filters that can both replace multiple fixed filters and improve RF performance. Skyworks is well known to be Resonant's first customer.
The second customer remains confidential, as does the frequency band under development. Resonant does state the filter design is expected to take less than a year to develop, and is meant to "replace a BAW (bulk acoustic wave) filter with a SAW (surface acoustic wave) filter for a hard band" - SAW filters are cheaper than BAW filters.
The customer plans to offer a duplexer enabled by the project to RF front end makers and mobile OEMs. Resonant notes the agreement isn't binding, but adds it gives the company "the flexibility to retain [its] technology while allowing our customer to decide whether to commercialize the design." Licensing terms will be negotiated if/when the customer decides to commercialize a product.
Shares are up to $14.40 AH. They rose 9.9% in regular trading ahead of the announcement, and (following last week's gains) have recovered most of the big post-earnings losses seen on Feb. 27. On Friday, SA author Benjamin Padnos speculated acquisition-hungry Avago - a leader in the BAW/FBAR filter market - could be interested in Resonant.

Resonant +10.9%; second customer announced

Resonant (NASDAQ:RESN) has landed "a second customer for the design of an RF filter" featuring the company's ISN technology, which aims to enable tunable filters that can both replace multiple fixed filters and improve RF performance. Skyworks is well known to be Resonant's first customer.
The second customer remains confidential, as does the frequency band under development. Resonant does state the filter design is expected to take less than a year to develop, and is meant to "replace a BAW (bulk acoustic wave) filter with a SAW (surface acoustic wave) filter for a hard band" - SAW filters are cheaper than BAW filters.
The customer plans to offer a duplexer enabled by the project to RF front end makers and mobile OEMs. Resonant notes the agreement isn't binding, but adds it gives the company "the flexibility to retain [its] technology while allowing our customer to decide whether to commercialize the design." Licensing terms will be negotiated if/when the customer decides to commercialize a product.
Shares are up to $14.40 AH. They rose 9.9% in regular trading ahead of the announcement, and (following last week's gains) have recovered most of the big post-earnings losses seen on Feb. 27. On Friday, SA author Benjamin Padnos speculated acquisition-hungry Avago - a leader in the BAW/FBAR filter market - could be interested in Resonant.

Mindray Medical misses by $0.02, misses on revenue

Mindray Medical (NYSE:MR): Q4 EPS of $0.50 misses by $0.02.
Revenue of $399M (+8.3% Y/Y) misses by $8.07M.

Mindray Medical misses by $0.02, misses on revenue

Mindray Medical (NYSE:MR): Q4 EPS of $0.50 misses by $0.02.
Revenue of $399M (+8.3% Y/Y) misses by $8.07M.

AirMedia Group reports Q4 results

AirMedia Group (NASDAQ:AMCN): Q4 EPS of -$0.09 vs. $0.01 in 4Q13
Revenue of $67.53M (-14.1% Y/Y)

Imperva plans 3M-share stock offering

Imperva (NYSE:IMPV) hasn't yet set pricing for its offering, which will increase the company's share count by a little over 10%. Net proceeds will be used for working capital and other corporate purposes, possibly including acquisitions. (PR)
The data-protection software vendor had $114M in cash/investments at the end of 2014, and no debt.
IMPV -1.3% AH to $44.89. Shares fell 1.5% in regular trading ahead of the announcement.

Imperva plans 3M-share stock offering

Imperva (NYSE:IMPV) hasn't yet set pricing for its offering, which will increase the company's share count by a little over 10%. Net proceeds will be used for working capital and other corporate purposes, possibly including acquisitions. (PR)
The data-protection software vendor had $114M in cash/investments at the end of 2014, and no debt.
IMPV -1.3% AH to $44.89. Shares fell 1.5% in regular trading ahead of the announcement.

Millennial Media +8.2% on Q4 beat, better-than-feared guidance

Millennial Media (NYSE:MM) expects Q1 revenue of $55M-$58M, below a sole analyst estimate of $66M. However, full-year revenue guidance of $311M-$342M is in-line with a $321.2M 2-analyst consensus, and going over well in light of Millennial's recent woes.
Q1 and full-year billings guidance is respectively at $69M-$72M and $435M-$459M. Between them, Millennial and recently-acquired supply-side mobile ad platform Nexage had 2014 revenue of $302.5M and billings of $348.3M.
Nexage, which Millennial finished acquiring on Dec. 4, had Q4 revenue of $3.6M and billings of $18.5M. Overall, Millennial reached 650M+ users globally (175M in the U.S.) at the end of Q4, and supported ~60K apps on its ad platform; both figures are flat Q/Q for the second straight quarter (previous).
Gross margin was 38.3% vs. 37.8% in Q3 and 38.7% a year ago. Millennial/Nexage's combined pro forma operating expenses totaled $42.6M; Millennial's year-ago GAAP operating expenses totaled $41.2M.
Adjusted EBITDA was -$1.8M. Millennial is guiding for Q1 adjusted EBITDA of -$14M to -$15M. Full-year adjusted EBITDA is simply expected to be "positive."
Shares have risen to $1.72 AH.

Millennial Media +8.2% on Q4 beat, better-than-feared guidance

Millennial Media (NYSE:MM) expects Q1 revenue of $55M-$58M, below a sole analyst estimate of $66M. However, full-year revenue guidance of $311M-$342M is in-line with a $321.2M 2-analyst consensus, and going over well in light of Millennial's recent woes.
Q1 and full-year billings guidance is respectively at $69M-$72M and $435M-$459M. Between them, Millennial and recently-acquired supply-side mobile ad platform Nexage had 2014 revenue of $302.5M and billings of $348.3M.
Nexage, which Millennial finished acquiring on Dec. 4, had Q4 revenue of $3.6M and billings of $18.5M. Overall, Millennial reached 650M+ users globally (175M in the U.S.) at the end of Q4, and supported ~60K apps on its ad platform; both figures are flat Q/Q for the second straight quarter (previous).
Gross margin was 38.3% vs. 37.8% in Q3 and 38.7% a year ago. Millennial/Nexage's combined pro forma operating expenses totaled $42.6M; Millennial's year-ago GAAP operating expenses totaled $41.2M.
Adjusted EBITDA was -$1.8M. Millennial is guiding for Q1 adjusted EBITDA of -$14M to -$15M. Full-year adjusted EBITDA is simply expected to be "positive."
Shares have risen to $1.72 AH.

Main Street Capital announces plans for secondary

The size of the offering is not specified. The shares closed at $31.14 today, a sizable premium to Dec. 31 book value per share of $20.85.
Source: Press Release
A shelf offering was filed in May 2014.
MAIN -1.55% after hours to $30.66.